Investors & media
Financial data
Find the latest press releases, financial information, and performance updates.
Transforming rare disease care
We are a specialty biopharmaceutical company expanding possibilities for people with rare diseases. With 50 years of experience in applying our scientific expertise and unique technologies to research, we continue to develop next-generation treatments and expand our global footprint to transform the lives of patients worldwide.
Newsroom
2025.06.06
JCR Pharmaceuticals marks 50 years of innovation with launch of one-of-a-kind global website
2025.06.06
Other matters subject to measures for electronic provision when convening the 50th ordinary general meeting of shareholders
2025.06.04
Notice of convocation of the 50th ordinary general meeting of shareholders
2025.05.19
[Updated] JCR Pharmaceuticals presents preclinical gene therapy data at ASGCT 28th Annual Meeting
2025.05.15
Financial data
JCR Pharmaceuticals (4552.T)
Tokyo Currency in JPY
572.00
+2.00
(+0.35%)
Last updated 06/09/2025 at TSE market close
Quarterly results
Driven by science and compassion, we tackle some of the most complex challenges in rare disease. Every solution we develop is grounded in insight into the genetic and biological foundations of the conditions we aim to treat.
Contact us
Investors & media